New Frameworks for Pitching AI to Executives

Getting executive buy-in for AI now requires a more structured approach, moving beyond pure technology pitches. Recent analysis highlights the use of formal AI readiness assessments to build consensus across business, tech, and legal teams. Experts like CEO Leon Gordon advocate for mapping AI initiatives directly to board-level objectives and embedding ownership within business units, not just IT, to ensure strategic alignment.

The success rate for AI projects remains alarmingly low, with some studies indicating that up to 70% of initiatives fail. The primary culprits are often a lack of data readiness and a disconnect between the project's goals and core business objectives. Formal assessments force a crucial alignment on strategy, data maturity, infrastructure, and talent before significant investment occurs. A key metric driving this structured approach is the pressure from CEOs to demonstrate AI's impact within 12 months. However, a significant 48% of companies admit they lack the in-house skills to manage production-level AI. This skills gap is a major barrier, with 98% of organizations citing it as an obstacle to scaling AI initiatives. In the biotech sector, AI is dramatically accelerating drug discovery timelines. For instance, companies like Insilico Medicine have used AI to move from target identification to a preclinical drug candidate in just 30 days. Similarly, Recursion Pharmaceuticals brought a cancer therapeutic from concept to human trials in 18 months, less than half the industry average. To overcome infrastructure hurdles without the high costs of major cloud providers, some biotech firms are turning to specialized GPU-as-a-service vendors. Athos Therapeutics, for example, opted for a niche provider to train its AI models for precision medicine, citing cost and infrastructure stability as key factors. This approach allows them to bring the AI platform to their proprietary data, rather than the other way around. Multi-cloud providers (MCPs) are becoming critical for biotech firms that need to balance the scalability of the public cloud with the security of on-premise data storage for sensitive intellectual property. This hybrid model allows companies to maintain data sovereignty and comply with regional regulations while still leveraging powerful AI and analytics tools from different cloud environments. Frameworks like the AI Readiness Index evaluate organizations across key dimensions including Purpose, People, Process, Platform, and Performance. These assessments provide a maturity score, moving from "AI Unaware" to "AI Operational," which helps leadership identify specific gaps in data governance, MLOps, and responsible AI practices before they derail a project. Ultimately, successful AI proposals now focus less on the technology itself and more on a clear articulation of the problem, the expected ROI, and a detailed plan for execution. This includes defining success metrics and key performance indicators from the outset to ensure the project delivers measurable business value rather than just a proof of concept.

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.